News Focus
News Focus
icon url

theorysuit

10/30/24 6:44 AM

#729194 RE: Investor082 #729193

Agree with everything you say.
Complaining and excuses and slow as sht execution is what you get from this company and their paid reps. Time to grow up, shut up and execute. I didn't know that this was possible that a company could drag out commercializing a drug THIS LONG. Unreal.
icon url

manibiotech

10/30/24 6:55 AM

#729195 RE: Investor082 #729193

Well said
But it is easier to blame everything under the sun and in the universe.
icon url

Goats'nCrows

10/30/24 7:03 AM

#729196 RE: Investor082 #729193

Just curious, I see that Novocure's current headcount is ~1,500 employees, can you point me to a headcount pre-approval?

Best.
icon url

XMaster2023

10/30/24 8:06 AM

#729198 RE: Investor082 #729193

No cure did not have five years plus of data No cure did Not have 73 co authors.
No cure used projected data.
No cure did not use OS as an end point.
My nephew used the electric POS helmet for about 6 months and it did not change a thing other than his savings account.
Do not compare DCVax-L to that POS.